Next-Generation Precision Medicine: Integrating Artificial Intelligence, Genomics, and Real-World Clinical Data for Disease Prediction and Personalized Therapy Optimization

Abstract

Precision medicine has evolved from a primarily genomics-centered framework into a complex, data-intensive paradigm that integrates molecular profiling, longitudinal clinical observations, and advanced computational analytics. Despite early promise, its translation into routine clinical practice has been constrained by fragmented data ecosystems, limited interoperability, and the challenge of extracting actionable insights from heterogeneous biomedical datasets. Recent advances in artificial intelligence have begun to reshape this landscape by enabling scalable interpretation of high-dimensional clinical and biological data, thereby accelerating the shift toward truly individualized healthcare.

This review examines the emerging convergence of artificial intelligence, multi-omics technologies, and real-world clinical data in the development of next-generation precision medicine systems. Machine learning and deep learning models are increasingly applied to genomic sequencing data, transcriptomic profiles, and proteomic signatures to identify disease-associated patterns that are not readily observable through conventional statistical approaches. At the same time, the integration of electronic health records, medical imaging, and wearable sensor data provides a longitudinal and context-rich view of patient health trajectories, enhancing the predictive accuracy of risk stratification models.

A key advancement lies in the fusion of multi-modal datasets, where AI-driven frameworks enable the alignment of molecular variability with phenotypic and environmental determinants of disease. This integration supports earlier disease detection, improved prognostic modeling, and more precise therapeutic selection across oncology, cardiometabolic disorders, and rare genetic diseases. Furthermore, emerging approaches in federated learning and privacy-preserving analytics are expanding the feasibility of large-scale data collaboration without compromising patient confidentiality.

Despite significant progress, challenges remain in data standardization, model interpretability, and clinical validation. Addressing these limitations will be essential for ensuring safe and equitable deployment of AI-enabled precision medicine systems. Collectively, the convergence of genomics, real-world data, and artificial intelligence is redefining disease prediction and therapeutic optimization, marking a critical step toward scalable and clinically actionable precision healthcare.